Skip to content

Hospital Innovation Programs Directory

An independent editorial resource published by Lisa T. Miller

Menu

Health system intelligence profile

Coulter Translational Research Partnership Program

Michigan Medicine / University of Michigan

Last reviewed August 30, 2026

Intelligence summary

Program at a Glance

Program mandate
The U-M Coulter Translational Research Partnership funds collaborative projects that pair a biomedical engineering faculty member with a Michigan Medicine clinical faculty member to accelerate development and commercialization of medical devices, diagnostics and other biomedical products addressing unmet clinical needs. Project teams receive translational funding plus commercialization coaching and milestone oversight from the program director and an oversight committee.
Organizational model
Academic · Nonprofit
Location
Ann Arbor, Michigan
Program types
Technology transferEntrepreneurship
Commercialization pathways
LicenseInvestmentStrategic partnership
Focus areas
ClinicalMedical deviceDiagnostics
Public scale or maturity signals

Established 2006

Official engagement route
Program website ↗Health system website ↗
Last reviewed
August 30, 2026

Mandate and remit

What This Program Does

The U-M Coulter Translational Research Partnership funds collaborative projects that pair a biomedical engineering faculty member with a Michigan Medicine clinical faculty member to accelerate development and commercialization of medical devices, diagnostics and other biomedical products addressing unmet clinical needs. Project teams receive translational funding plus commercialization coaching and milestone oversight from the program director and an oversight committee. Success is measured by whether a funded concept advances far enough to attract an industry licensee or to launch a startup that raises investor capital. The program is housed in the Department of Biomedical Engineering at Michigan Engineering and works alongside the university's technology transfer and venture teams.

Areas of Focus

ClinicalMedical deviceDiagnostics

Commercialization Pathways

These routes appear in the program's sourced public record.

Leadership and Structure

Organizational home: Coulter Translational Research Partnership Program, Michigan Medicine / University of Michigan

  • Thomas MartenCoulter Program Director

Contact the Program

Use the program's published contact route for partnership, licensing, innovation, or program inquiries.

Program phone
(734) 647-1680
Official contact page
Open contact page ↗

Related Programs

Comparable records based on shared public taxonomy, location, or commercialization route.

Same state · Same program type · Same commercialization route

Royal Oak, Michigan

Corewell Health

Corewell Health Innovations Office

The Innovations Office is Corewell Health's commercialization arm, housed within the Corewell Health Research Institute in Southeast Michigan, that turns employee and researcher ideas into products, services or licenses.

Technology transferLicenseInvestmentClinicalWorkforce

Nonprofit

Read the intelligence brief

Reviewed August 30, 2026

Same state · Same program type · Same commercialization route

Detroit, Michigan

Henry Ford Health

Henry Ford Innovations

Henry Ford Innovations advances inventions developed by Henry Ford Health clinicians and researchers while also sourcing external technologies for the system.

Innovation centerVenture fundPhysician innovationInvestmentStrategic partnershipClinicalWorkforce

Nonprofit

Read the intelligence brief

Editorially verified · Reviewed August 30, 2026

Same state · Same program type · Same commercialization route

Detroit, Michigan

Henry Ford Health

Henry Ford + MSU Innovation Fund (Henry Ford Innovations)

Henry Ford Health and Michigan State University launched a joint Innovation Hub in 2025 anchored by a $10 million venture fund, the Henry Ford + MSU Innovation Fund, managed with the MSU Research Foundation.

Venture fundInnovation centerTechnology transferLicenseInvestmentClinicalArtificial intelligenceMedical device

Nonprofit

Read the intelligence brief

Editorially verified · Reviewed August 30, 2026

Same state · Same program type · Same commercialization route

Ann Arbor, Michigan

Michigan Medicine

Fast Forward Medical Innovation

Michigan Medicine's Fast Forward Medical Innovation (FFMI) is an official biomedical commercialization and entrepreneurship program that describes itself as a front door to biomedical commercialization at the University of Michigan.

Innovation centerTechnology transferAcceleratorLicenseSpinoutClinicalMedical deviceDiagnostics

Academic

Read the intelligence brief

Editorially verified · Reviewed August 30, 2026

Same state · Same program type · Same commercialization route

Ann Arbor, Michigan

Michigan Medicine / University of Michigan

U-M Innovation Partnerships

Innovation Partnerships is the University of Michigan's central technology transfer and commercialization unit, handling invention disclosures, patents and licenses for the entire university including Michigan Medicine's clinical and biomedical research.

Technology transferVenture fundEntrepreneurshipLicenseSpinoutClinical

Academic · Nonprofit

Read the intelligence brief

Reviewed August 30, 2026

Same state · Same program type · Same commercialization route

Ann Arbor, Michigan

Michigan Medicine / University of Michigan Medical School

Michigan Biomedical Venture Fund

The Michigan Biomedical Venture Fund is an early-stage investment program within Fast Forward Medical Innovation at the University of Michigan Medical School.

Venture fundTechnology transferEntrepreneurshipInvestmentSpinoutClinicalMedical deviceTherapeutics

Academic · Nonprofit

Read the intelligence brief

Editorially verified · Reviewed August 30, 2026

Sources and Updates

Reviewed August 30, 2026. External source links open in a new tab.

  1. Coulter Translational Research Partnership Program official source coulter.bme.umich.edu. Accessed August 30, 2026.

Confidential comparison

How does your innovation program compare?

Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio. The public directory does not score or rank programs.